3-amino-6-methyl-5-phenyl-2(1h)-pyridinone has been researched along with sulmazole in 1 studies
Studies (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Trials (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Recent Studies (post-2010) (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Studies (sulmazole) | Trials (sulmazole) | Recent Studies (post-2010) (sulmazole) |
---|---|---|---|---|---|
11 | 0 | 0 | 213 | 5 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forest, MC; Lahouratate, P; Martin, M; Nadler, G; Quiniou, MJ; Zimmermann, RG | 1 |
1 other study(ies) available for 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone and sulmazole
Article | Year |
---|---|
A novel class of cardiotonic agents: synthesis and biological evaluation of 5-substituted 3,6-dihydrothiadiazin-2-ones with cyclic AMP phosphodiesterase inhibiting and myofibrillar calcium sensitizing properties.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Cardiotonic Agents; Dogs; Female; Guinea Pigs; Heart; Indoles; Male; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Structure-Activity Relationship; Thiadiazines | 1992 |